Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

NCT05412004 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

469

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea
Obesity

Interventions

DRUG: Tirzepatide
DRUG: Placebo

Sponsor

Eli Lilly and Company